Kevin Hicok, Head of Research and Development at Direct Biologics, seen here pulling ExoFlo out of dry ice at Direct Biologics Research & Development Laboratories University of California. Doctors have been amazed by this new Innovative COVID-19 Treatment ExoFlo. The treatment fulfills an unmet but urgent medical need. Medical professionals are enthusiastic about unlocked potential of regenerative properties of bone marrow mesenchymal stem cell (MSC)-derived extracellular vesicles and ExoFlo. ExoFlo Represents a New Frontier in Regenerative Health Solutions. Photo: imageSPACE for Direct Biolog
Image details
Contributor:
Imagespace / Alamy Stock PhotoImage ID:
2E5WF1FFile size:
46.2 MB (918.9 KB Compressed download)Releases:
Model - no | Property - noDo I need a release?Dimensions:
3280 x 4928 px | 27.8 x 41.7 cm | 10.9 x 16.4 inches | 300dpiDate taken:
27 January 2021Photographer:
imageSPACEMore information:
This image could have imperfections as it’s either historical or reportage.
Kevin Hicok, Head of Research and Development at Direct Biologics, seen here pulling ExoFlo out of dry ice at Direct Biologics Research & Development Laboratories University of California. Doctors have been amazed by this new Innovative COVID-19 Treatment ExoFlo. The treatment fulfills an unmet but urgent medical need. Medical professionals are enthusiastic about unlocked potential of regenerative properties of bone marrow mesenchymal stem cell (MSC)-derived extracellular vesicles and ExoFlo. ExoFlo Represents a New Frontier in Regenerative Health Solutions. Photo: imageSPACE for Direct Biologics Research